First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study
Date issued
2012Journal title
ONCOLOGIST
Type of content
Artigo